Thymulin

CAS No. 63958-90-7

Thymulin( —— )

Catalog No. M24653 CAS No. 63958-90-7

Thymulin is a peptide hormone which is mainly produced by thymic epithelial cells and it has immune-modulatory and anti-inflammatory effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 85 In Stock
10MG 128 In Stock
25MG 215 In Stock
50MG 312 In Stock
100MG 456 In Stock
200MG 663 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thymulin
  • Note
    Research use only, not for human use.
  • Brief Description
    Thymulin is a peptide hormone which is mainly produced by thymic epithelial cells and it has immune-modulatory and anti-inflammatory effects.
  • Description
    Thymulin is a peptide hormone which is mainly produced by thymic epithelial cells and it has immune-modulatory and anti-inflammatory effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Immunology & Inflammation related
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    63958-90-7
  • Formula Weight
    858.9
  • Molecular Formula
    C33H54N12O15?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Insoluble;Water:10 mM
  • SMILES
    C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@@H]1CCC(=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Behzad, Nasseri, Jalal,et al. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways.[J]. International immunopharmacology, 2019.
molnova catalog
related products
  • JI-101

    JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).

  • 6RK73

    6RK73 is a covalent irreversible and specific UCHL1 inhibitor (IC50: 0.23 μM).

  • Myosin Kinase Inhibi...

    Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.